Home
Scholarly Works
NCIC CTG IND102: a phase II study of the oral...
Journal article

NCIC CTG IND102: a phase II study of the oral platinum compound BMS-182751 in patients with advanced and or recurrent squamous cell carcinoma of the cervix

Authors

Trudeau M; Stuart G; Hirte H; Drouin P; Plante M; Bessette P; Dulude H; Lebwohl D

Journal

European Journal of Cancer, Vol. 35, ,

Publisher

Elsevier

Publication Date

September 1, 1999

DOI

10.1016/s0959-8049(99)81342-2

ISSN

0959-8049

Contact the Experts team